具有内在抗炎活性的ROS响应性阴离子聚合物用于细胞内蛋白质输送
Yongming Wang1, Yangcan Ming2, Zhichao Yu3
1College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China.
Biomacromolecules
|March 21, 2025
概括
一种新型的聚合物,乙烯胺-硫基甲 (OEI-TK),有效地将蛋白质药物输送到细胞中,同时减少炎症. 这种双作用纳米载体平台在治疗炎症性疾病方面表现有前途.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 纳米载体对于细胞内蛋白质药物输送至关重要,但通常会触发免疫反应和炎症,限制它们的治疗用途.
- 开发可绕过免疫激活的安全有效的纳米载体对于推进基于蛋白质的疗法至关重要.
研究的目的:
- 开发一种新型的阴离子聚合物,乙胺-硫基甲 (OEI-TK),具有固有的抗炎性质,用于增强细胞内蛋白质的输送.
- 使用OEI-TK和牛血清白蛋白 (BSA) 创建稳定的纳米粒子 (OTB NP),并评估它们在治疗应用中的潜力.
主要方法:
- OEI-TK被合成为一种反应性氧物种反应性聚合物.
- 通过静电相互作用,OEI-TK与BSA自组装形成OTB NP.
- 在体外研究中评估了纳米粒子稳定性,封装效率,抗氧化和抗炎性质,细胞吸收和蛋白质传递效率.
主要成果:
- OTB NPs表现出极好的封装效率和稳定性.
- 这些纳米颗粒表明OEI-TK的抗氧化和抗炎性质保留,以及增强的生物相容性.
- 实现了BSA的有效细胞内输送和β-银酸酶的功能性输送,保持了酶活性.
结论:
- OEI-TK是一种有前途的平台,可以调节炎症并促进细胞内蛋白质的输送.
- 在疾病治疗中,OTB NP提供了双重治疗效益,解决蛋白质输送和炎症.
- 这项技术在与炎症相关的疾病中具有协同治疗策略的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Oral Drug Delivery Systems: Delayed-Release Systems
222
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
222


